Dabigatran
Top View
- Combining Antiplatelets and Anticoagulants Example
- Scientific Abstracts Thursday, 15 June 2017
- Risk Factors for Bleeding Events with Enoxaparin, Dabigatran And
- Rivaroxaban: a Fully-Subsidised Oral Anticoagulant
- (Doacs) APIXABAN/DABIGATRAN/EDOXABAN/RIVAROXABAN
- Effects of the Oral, Direct Thrombin Inhibitor Dabigatran on Five Common Coagulation Assays
- Guidance on Safe Switching of Warfarin to DOAC
- Prescriptions of Direct Oral Anticoagulants in Patients Admitted
- Bericht ATC-Code B01: Antithrombotische Mittel
- Anticoagulants and Osteoporosis
- Direct Oral Anticoagulants: from Randomized Clinical Trials to Real-World Clinical Practice
- MEDICATION GUIDE PRADAXA (Pra Dax A) (Dabigatran Etexilate Mesylate) Capsules
- Management of Dental Patients Taking Anticoagulants Or Antiplatelets
- Oral Direct Thrombin Inhibitors Or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism (Review)
- Guidelines for Management of Bleeding with Dabigatran Or Rivaroxaban: for Possible Use in Local Management Protocols
- Clinical Trial Protocol Doc
- Direct-Acting Oral Anticoagulant Use at Extremes of Body Weight
- Report on the Deliberation Results December 1, 2010 Evaluation And